Selected research
Market Outlook & Growth Opportunities
Global Rapid Covid-19 Antigen Test Kit Market Outlook and Growth Opportunities 2026
Market perspective
The global Rapid Covid-19 Antigen Test Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Rapid Covid-19 Antigen Test Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Rapid Covid-19 Antigen Test Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rapid Covid-19 Antigen Test Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Rapid Covid-19 Antigen Test Kit market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Rapid Covid-19 Antigen Test Kit market include Phase Scientific, AUISET, Lepu Medical Technology, BGI, Biotest Biotech, BIOHIT Healthcare (Hefei), Hangzhou AllTest Biotech, Assure Tech and ACON Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Rapid Covid-19 Antigen Test Kit market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Rapid Covid-19 Antigen Test Kit and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Rapid Covid-19 Antigen Test Kit sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rapid Covid-19 Antigen Test Kit market size, projected growth trends, production technologies, key applications, and end-use industries.
Rapid Covid-19 Antigen Test Kit Segment by Company
Phase Scientific
AUISET
Lepu Medical Technology
BGI
Biotest Biotech
BIOHIT Healthcare (Hefei)
Hangzhou AllTest Biotech
Assure Tech
ACON Biotech
SD Biosensor
ROCHE DIAGNOSTICS
Quidel
Philosys
Medriva
JOYSBIO
Innovation Scientific
IHealth
GenBody Inc
CTK Biotech
Artron Laboratories
ARISTA® Biotech
AESKU.GROUP
ACCESS BIO
Abbott
Rapid Covid-19 Antigen Test Kit Segment by Type
Nasal Swab
Nasopharyngeal Swab
Oropharyngeal Swab
Saliva Swab
Rapid Covid-19 Antigen Test Kit Segment by Application
Home
Company
School
Hospital
Others
Rapid Covid-19 Antigen Test Kit Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Rapid Covid-19 Antigen Test Kit status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Rapid Covid-19 Antigen Test Kit market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Rapid Covid-19 Antigen Test Kit significant trends, drivers, influence factors in global and regions.
6. To analyze Rapid Covid-19 Antigen Test Kit competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid Covid-19 Antigen Test Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rapid Covid-19 Antigen Test Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid Covid-19 Antigen Test Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Rapid Covid-19 Antigen Test Kit market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rapid Covid-19 Antigen Test Kit industry.
Chapter 3: Detailed analysis of Rapid Covid-19 Antigen Test Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Rapid Covid-19 Antigen Test Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Rapid Covid-19 Antigen Test Kit in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Nasal Swab
- Nasopharyngeal Swab
- Oropharyngeal Swab
- Saliva Swab
Applications
- Home
- Company
- School
- Hospital
- Others
Companies covered
- Phase Scientific
- AUISET
- Lepu Medical Technology
- BGI
- Biotest Biotech
- BIOHIT Healthcare (Hefei)
- Hangzhou AllTest Biotech
- Assure Tech
- ACON Biotech
- SD Biosensor
- ROCHE DIAGNOSTICS
- Quidel
- Philosys
- Medriva
- JOYSBIO
- Innovation Scientific
- IHealth
- GenBody Inc
- CTK Biotech
- Artron Laboratories
- ARISTA® Biotech
- AESKU.GROUP
- ACCESS BIO
- Abbott
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Rapid Covid-19 Antigen Test Kit Sales Value (2021-2032)
- 1.2.2 Global Rapid Covid-19 Antigen Test Kit Sales Volume (2021-2032)
- 1.2.3 Global Rapid Covid-19 Antigen Test Kit Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Rapid Covid-19 Antigen Test Kit Market Dynamics
- 2.1 Rapid Covid-19 Antigen Test Kit Industry Trends
- 2.2 Rapid Covid-19 Antigen Test Kit Industry Drivers
- 2.3 Rapid Covid-19 Antigen Test Kit Industry Opportunities and Challenges
- 2.4 Rapid Covid-19 Antigen Test Kit Industry Restraints
3 Rapid Covid-19 Antigen Test Kit Market by Company
- 3.1 Global Rapid Covid-19 Antigen Test Kit Company Revenue Ranking in 2025
- 3.2 Global Rapid Covid-19 Antigen Test Kit Revenue by Company (2021-2026)
- 3.3 Global Rapid Covid-19 Antigen Test Kit Sales Volume by Company (2021-2026)
- 3.4 Global Rapid Covid-19 Antigen Test Kit Average Price by Company (2021-2026)
- 3.5 Global Rapid Covid-19 Antigen Test Kit Company Ranking (2024-2026)
- 3.6 Global Rapid Covid-19 Antigen Test Kit Company Manufacturing Base and Headquarters
- 3.7 Global Rapid Covid-19 Antigen Test Kit Company Product Type and Application
- 3.8 Global Rapid Covid-19 Antigen Test Kit Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Rapid Covid-19 Antigen Test Kit Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Rapid Covid-19 Antigen Test Kit Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Rapid Covid-19 Antigen Test Kit Market by Type
- 4.1 Rapid Covid-19 Antigen Test Kit Type Introduction
- 4.1.1 Nasal Swab
- 4.1.2 Nasopharyngeal Swab
- 4.1.3 Oropharyngeal Swab
- 4.1.4 Saliva Swab
- 4.2 Global Rapid Covid-19 Antigen Test Kit Sales Volume by Type
- 4.2.1 Global Rapid Covid-19 Antigen Test Kit Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Rapid Covid-19 Antigen Test Kit Sales Volume by Type (2021-2032)
- 4.2.3 Global Rapid Covid-19 Antigen Test Kit Sales Volume Share by Type (2021-2032)
- 4.3 Global Rapid Covid-19 Antigen Test Kit Sales Value by Type
- 4.3.1 Global Rapid Covid-19 Antigen Test Kit Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Rapid Covid-19 Antigen Test Kit Sales Value by Type (2021-2032)
- 4.3.3 Global Rapid Covid-19 Antigen Test Kit Sales Value Share by Type (2021-2032)
5 Rapid Covid-19 Antigen Test Kit Market by Application
- 5.1 Rapid Covid-19 Antigen Test Kit Application Introduction
- 5.1.1 Home
- 5.1.2 Company
- 5.1.3 School
- 5.1.4 Hospital
- 5.1.5 Others
- 5.2 Global Rapid Covid-19 Antigen Test Kit Sales Volume by Application
- 5.2.1 Global Rapid Covid-19 Antigen Test Kit Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Rapid Covid-19 Antigen Test Kit Sales Volume by Application (2021-2032)
- 5.2.3 Global Rapid Covid-19 Antigen Test Kit Sales Volume Share by Application (2021-2032)
- 5.3 Global Rapid Covid-19 Antigen Test Kit Sales Value by Application
- 5.3.1 Global Rapid Covid-19 Antigen Test Kit Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Rapid Covid-19 Antigen Test Kit Sales Value by Application (2021-2032)
- 5.3.3 Global Rapid Covid-19 Antigen Test Kit Sales Value Share by Application (2021-2032)
6 Rapid Covid-19 Antigen Test Kit Regional Sales and Value Analysis
- 6.1 Global Rapid Covid-19 Antigen Test Kit Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Rapid Covid-19 Antigen Test Kit Sales by Region (2021-2032)
- 6.2.1 Global Rapid Covid-19 Antigen Test Kit Sales by Region: 2021-2026
- 6.2.2 Global Rapid Covid-19 Antigen Test Kit Sales by Region (2027-2032)
- 6.3 Global Rapid Covid-19 Antigen Test Kit Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Rapid Covid-19 Antigen Test Kit Sales Value by Region (2021-2032)
- 6.4.1 Global Rapid Covid-19 Antigen Test Kit Sales Value by Region: 2021-2026
- 6.4.2 Global Rapid Covid-19 Antigen Test Kit Sales Value by Region (2027-2032)
- 6.5 Global Rapid Covid-19 Antigen Test Kit Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Rapid Covid-19 Antigen Test Kit Sales Value (2021-2032)
- 6.6.2 North America Rapid Covid-19 Antigen Test Kit Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Rapid Covid-19 Antigen Test Kit Sales Value (2021-2032)
- 6.7.2 Europe Rapid Covid-19 Antigen Test Kit Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Rapid Covid-19 Antigen Test Kit Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Rapid Covid-19 Antigen Test Kit Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Rapid Covid-19 Antigen Test Kit Sales Value (2021-2032)
- 6.9.2 South America Rapid Covid-19 Antigen Test Kit Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Rapid Covid-19 Antigen Test Kit Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Rapid Covid-19 Antigen Test Kit Sales Value Share by Country, 2025 VS 2032
7 Rapid Covid-19 Antigen Test Kit Country-level Sales and Value Analysis
- 7.1 Global Rapid Covid-19 Antigen Test Kit Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Rapid Covid-19 Antigen Test Kit Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Rapid Covid-19 Antigen Test Kit Sales by Country (2021-2032)
- 7.3.1 Global Rapid Covid-19 Antigen Test Kit Sales by Country (2021-2026)
- 7.3.2 Global Rapid Covid-19 Antigen Test Kit Sales by Country (2027-2032)
- 7.4 Global Rapid Covid-19 Antigen Test Kit Sales Value by Country (2021-2032)
- 7.4.1 Global Rapid Covid-19 Antigen Test Kit Sales Value by Country (2021-2026)
- 7.4.2 Global Rapid Covid-19 Antigen Test Kit Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.9.2 France Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.16.2 China Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.19.2 India Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Rapid Covid-19 Antigen Test Kit Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Rapid Covid-19 Antigen Test Kit Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Rapid Covid-19 Antigen Test Kit Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Phase Scientific
- 8.1.1 Phase Scientific Company Information
- 8.1.2 Phase Scientific Business Overview
- 8.1.3 Phase Scientific Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Phase Scientific Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.1.5 Phase Scientific Recent Developments
- 8.2 AUISET
- 8.2.1 AUISET Company Information
- 8.2.2 AUISET Business Overview
- 8.2.3 AUISET Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.2.4 AUISET Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.2.5 AUISET Recent Developments
- 8.3 Lepu Medical Technology
- 8.3.1 Lepu Medical Technology Company Information
- 8.3.2 Lepu Medical Technology Business Overview
- 8.3.3 Lepu Medical Technology Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Lepu Medical Technology Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.3.5 Lepu Medical Technology Recent Developments
- 8.4 BGI
- 8.4.1 BGI Company Information
- 8.4.2 BGI Business Overview
- 8.4.3 BGI Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.4.4 BGI Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.4.5 BGI Recent Developments
- 8.5 Biotest Biotech
- 8.5.1 Biotest Biotech Company Information
- 8.5.2 Biotest Biotech Business Overview
- 8.5.3 Biotest Biotech Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Biotest Biotech Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.5.5 Biotest Biotech Recent Developments
- 8.6 BIOHIT Healthcare (Hefei)
- 8.6.1 BIOHIT Healthcare (Hefei) Company Information
- 8.6.2 BIOHIT Healthcare (Hefei) Business Overview
- 8.6.3 BIOHIT Healthcare (Hefei) Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.6.4 BIOHIT Healthcare (Hefei) Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.6.5 BIOHIT Healthcare (Hefei) Recent Developments
- 8.7 Hangzhou AllTest Biotech
- 8.7.1 Hangzhou AllTest Biotech Company Information
- 8.7.2 Hangzhou AllTest Biotech Business Overview
- 8.7.3 Hangzhou AllTest Biotech Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Hangzhou AllTest Biotech Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.7.5 Hangzhou AllTest Biotech Recent Developments
- 8.8 Assure Tech
- 8.8.1 Assure Tech Company Information
- 8.8.2 Assure Tech Business Overview
- 8.8.3 Assure Tech Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Assure Tech Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.8.5 Assure Tech Recent Developments
- 8.9 ACON Biotech
- 8.9.1 ACON Biotech Company Information
- 8.9.2 ACON Biotech Business Overview
- 8.9.3 ACON Biotech Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.9.4 ACON Biotech Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.9.5 ACON Biotech Recent Developments
- 8.10 SD Biosensor
- 8.10.1 SD Biosensor Company Information
- 8.10.2 SD Biosensor Business Overview
- 8.10.3 SD Biosensor Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.10.4 SD Biosensor Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.10.5 SD Biosensor Recent Developments
- 8.11 ROCHE DIAGNOSTICS
- 8.11.1 ROCHE DIAGNOSTICS Company Information
- 8.11.2 ROCHE DIAGNOSTICS Business Overview
- 8.11.3 ROCHE DIAGNOSTICS Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.11.4 ROCHE DIAGNOSTICS Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.11.5 ROCHE DIAGNOSTICS Recent Developments
- 8.12 Quidel
- 8.12.1 Quidel Company Information
- 8.12.2 Quidel Business Overview
- 8.12.3 Quidel Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Quidel Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.12.5 Quidel Recent Developments
- 8.13 Philosys
- 8.13.1 Philosys Company Information
- 8.13.2 Philosys Business Overview
- 8.13.3 Philosys Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Philosys Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.13.5 Philosys Recent Developments
- 8.14 Medriva
- 8.14.1 Medriva Company Information
- 8.14.2 Medriva Business Overview
- 8.14.3 Medriva Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Medriva Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.14.5 Medriva Recent Developments
- 8.15 JOYSBIO
- 8.15.1 JOYSBIO Company Information
- 8.15.2 JOYSBIO Business Overview
- 8.15.3 JOYSBIO Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.15.4 JOYSBIO Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.15.5 JOYSBIO Recent Developments
- 8.16 Innovation Scientific
- 8.16.1 Innovation Scientific Company Information
- 8.16.2 Innovation Scientific Business Overview
- 8.16.3 Innovation Scientific Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Innovation Scientific Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.16.5 Innovation Scientific Recent Developments
- 8.17 IHealth
- 8.17.1 IHealth Company Information
- 8.17.2 IHealth Business Overview
- 8.17.3 IHealth Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.17.4 IHealth Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.17.5 IHealth Recent Developments
- 8.18 GenBody Inc
- 8.18.1 GenBody Inc Company Information
- 8.18.2 GenBody Inc Business Overview
- 8.18.3 GenBody Inc Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.18.4 GenBody Inc Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.18.5 GenBody Inc Recent Developments
- 8.19 CTK Biotech
- 8.19.1 CTK Biotech Company Information
- 8.19.2 CTK Biotech Business Overview
- 8.19.3 CTK Biotech Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.19.4 CTK Biotech Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.19.5 CTK Biotech Recent Developments
- 8.20 Artron Laboratories
- 8.20.1 Artron Laboratories Company Information
- 8.20.2 Artron Laboratories Business Overview
- 8.20.3 Artron Laboratories Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Artron Laboratories Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.20.5 Artron Laboratories Recent Developments
- 8.21 ARISTA® Biotech
- 8.21.1 ARISTA® Biotech Company Information
- 8.21.2 ARISTA® Biotech Business Overview
- 8.21.3 ARISTA® Biotech Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.21.4 ARISTA® Biotech Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.21.5 ARISTA® Biotech Recent Developments
- 8.22 AESKU.GROUP
- 8.22.1 AESKU.GROUP Company Information
- 8.22.2 AESKU.GROUP Business Overview
- 8.22.3 AESKU.GROUP Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.22.4 AESKU.GROUP Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.22.5 AESKU.GROUP Recent Developments
- 8.23 ACCESS BIO
- 8.23.1 ACCESS BIO Company Information
- 8.23.2 ACCESS BIO Business Overview
- 8.23.3 ACCESS BIO Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.23.4 ACCESS BIO Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.23.5 ACCESS BIO Recent Developments
- 8.24 Abbott
- 8.24.1 Abbott Company Information
- 8.24.2 Abbott Business Overview
- 8.24.3 Abbott Rapid Covid-19 Antigen Test Kit Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Abbott Rapid Covid-19 Antigen Test Kit Product Portfolio
- 8.24.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Rapid Covid-19 Antigen Test Kit Value Chain Analysis
- 9.1.1 Rapid Covid-19 Antigen Test Kit Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Rapid Covid-19 Antigen Test Kit Sales Mode & Process
- 9.2 Rapid Covid-19 Antigen Test Kit Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Rapid Covid-19 Antigen Test Kit Distributors
- 9.2.3 Rapid Covid-19 Antigen Test Kit Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst